For: | Dorfman JD, Schulick R, Choti MA, Geschwind JFH, Kamel I, Torbenson M, Thuluvath PJ. Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States. World J Gastroenterol 2007; 13(5): 781-784 [PMID: 17278203 DOI: 10.3748/wjg.v13.i5.781] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i5/781.htm |
Number | Citing Articles |
1 |
Martin Zalesak, Kevin Francis, Alex Gedeon, John Gillis, Kyle Hvidsten, Phyllis Kidder, Hong Li, Derek Martyn, Leslie Orne, Amanda Smith, Ann Kwong, Yury E. Khudyakov. Current and Future Disease Progression of the Chronic HCV Population in the United States. PLoS ONE 2013; 8(5): e63959 doi: 10.1371/journal.pone.0063959
|
2 |
Shukui Qin, Qiu Li, Shanzhi Gu, Xiaoming Chen, Lizhu Lin, Zishu Wang, Aibing Xu, Xi Chen, Cuncai Zhou, Zhenggang Ren, Lin Yang, Li Xu, Yuxian Bai, Lei Chen, Jun Li, Hongming Pan, Bangwei Cao, Weijia Fang, Wei Wu, Ge Wang, Ying Cheng, Zhuang Yu, Xu Zhu, Da Jiang, Yinying Lu, Huaming Wang, Jianming Xu, Li Bai, Yunpeng Liu, Hailan Lin, Changping Wu, Yang Zhang, Ping Yan, Chunlei Jin, Jianjun Zou. Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. The Lancet Gastroenterology & Hepatology 2021; 6(7): 559 doi: 10.1016/S2468-1253(21)00109-6
|
3 |
H. Razavi, I. Waked, C. Sarrazin, R. P. Myers, R. Idilman, F. Calinas, W. Vogel, M. C. Mendes Correa, C. Hézode, P. Lázaro, U. Akarca, S. Aleman, İ. Balık, T. Berg, F. Bihl, M. Bilodeau, A. J. Blasco, C. E. Brandão Mello, P. Bruggmann, M. Buti, J. L. Calleja, H. Cheinquer, P. B. Christensen, M. Clausen, H. S. M. Coelho, M. E. Cramp, G. J. Dore, W. Doss, A. S. Duberg, M. H. El‐Sayed, G. Ergör, G. Esmat, K. Falconer, J. Félix, M. L. G. Ferraz, P. R. Ferreira, S. Frankova, J. García‐Samaniego, J. Gerstoft, J. A. Giria, F. L. Gonçales, E. Gower, M. Gschwantler, M. Guimarães Pessôa, S. J. Hindman, H. Hofer, P. Husa, M. Kåberg, K. D. E. Kaita, A. Kautz, S. Kaymakoglu, M. Krajden, H. Krarup, W. Laleman, D. Lavanchy, R. T. Marinho, P. Marotta, S. Mauss, C. Moreno, K. Murphy, F. Negro, V. Nemecek, N. Örmeci, A. L. H. Øvrehus, J. Parkes, K. Pasini, K. M. Peltekian, A. Ramji, N. Reis, S. K. Roberts, W. M. Rosenberg, F. Roudot‐Thoraval, S. D. Ryder, R. Sarmento‐Castro, D. Semela, M. Sherman, G. E. Shiha, W. Sievert, J. Sperl, P. Stärkel, R. E. Stauber, A. J. Thompson, P. Urbanek, P. Van Damme, I. van Thiel, H. Van Vlierberghe, D. Vandijck, H. Wedemeyer, N. Weis, J. Wiegand, A. Yosry, A. Zekry, M. Cornberg, B. Müllhaupt, C. Estes. The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. Journal of Viral Hepatitis 2014; 21(s1): 34 doi: 10.1111/jvh.12248
|
4 |
Kanokwan Pinyopornpanish, Wael Al-Yaman, Srinivasan Dasarathy, Carlos Romero-Marrero, Arthur McCullough. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. Digestive Diseases and Sciences 2022; 67(6): 2677 doi: 10.1007/s10620-021-07048-5
|
5 |
Caitlin A. McIntyre, Joanne F. Chou, Mithat Gonen, Jinru Shia, Maya Gambarin-Gelwan, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Jeffrey A. Drebin, William R. Jarnagin, Michael I. D'Angelica. Hepatocellular carcinoma in patients with no identifiable risk factors. HPB 2021; 23(1): 118 doi: 10.1016/j.hpb.2020.05.005
|
6 |
Mirko Tarocchi, Simone Polvani, Giada Marroncini, Andrea Galli. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World Journal of Gastroenterology 2014; 20(33): 11630-11640 doi: 10.3748/wjg.v20.i33.11630
|
7 |
Alan P. Venook, Christos Papandreou, Junji Furuse, Laura Ladrón de Guevara. The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective. The Oncologist 2010; 15(S4): 5 doi: 10.1634/theoncologist.2010-S4-05
|